Who
James Cullen
Director
Company insider
Files Form 4 as: Director, Keysight Technologies; Director, Avinger; Director, Neustar; Director, Agilent Technologies; Director, Prudential Financial; Director, Johnson & Johnson.
In numbers
- Trades disclosed
- 347
- Buys
- 1
- Sells
- 35
- Bought
- $42K
- Sold
- $20.6M
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 1 Jan 2006
- Last trade
- 2 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 5 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jun 2026filed 4 Jun 2026 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Sold | $1.0M3,000 at $346.58 | filing |
| 2 Jun 2026filed 4 Jun 2026 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Sold | $1.0M3,000 at $346.58 | filing |
| 20 Mar 2026filed 24 Mar 2026 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Code A | —870 at $0.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Code A | —870 at $0.00 | filing |
| 21 Mar 2025filed 25 Mar 2025 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Code A | —1,589 at $0.00 | filing |
| 22 Mar 2024filed 26 Mar 2024 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Code A | —1,632 at $0.00 | filing |
| 11 Jan 2024filed 17 Jan 2024 | Avinger | SEC FORM 4 Code A | —25,597 at $0.00 | filing |
| 11 Dec 2023filed 13 Dec 2023 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Sold | $713K4,869 at $146.47 | filing |
| 17 Mar 2023filed 21 Mar 2023 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Code A | —1,543 at $0.00 | filing |
| 18 Jan 2023filed 20 Jan 2023 | Avinger | SEC FORM 4 Code A | —60,976 at $0.00 | filing |
| 18 Mar 2022filed 22 Mar 2022 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Code A | —1,626 at $0.00 | filing |
| 14 Dec 2021filed 15 Dec 2021 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Sold | $1.4M7,000 at $196.45 | filing |
| 30 Nov 2021filed 30 Nov 2021 | Avinger | SEC FORM 4 Sold | $105184 at $0.57 | filing |
| 24 Nov 2021filed 26 Nov 2021 | Avinger | SEC FORM 4 Sold | $2032 at $0.62 | filing |
| 19 Mar 2021filed 23 Mar 2021 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Code A | —1,631 at $0.00 | filing |
| 18 Sep 2020filed 21 Sep 2020 | Avingeroption or derivative | SEC FORM 4 Code M | —65,217 at $0.00 | filing |
| 18 Sep 2020filed 21 Sep 2020 | Avinger | SEC FORM 4 Code M | —65,217 | filing |
| 20 Mar 2020filed 23 Mar 2020 | KEYS Keysight TechnologiesLife-science tools | SEC FORM 4 Code A | —2,438 at $0.00 | filing |
| 18 Sep 2019filed 20 Sep 2019 | Avingeroption or derivative | SEC FORM 4 Code A | —65,217 at $0.00 | filing |
| 5 Sep 2019filed 9 Sep 2019 | Avingeroption or derivative | SEC FORM 4 Code M | —4,602 at $0.00 | filing |
News
James Cullen Bressack's Horror Film 'I Have Proof' Debuts Teaser Trailer and Key Artaceshowbiz.com · 21 Sep 2026NSW premier's top staffer James Cullen in High Court showdown over potential arrest powersabc.net.au · 11 Sep 2026Keysight Technologies Inc RNS Announcements | 0A7N RNS AnnouncementsKEYS · investegate.co.uk · 15 Oct 2026
2 headlines in the last 90 days name James Cullen; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.